- Home
- ETON vs GNTA Comparison
ETON vs GNTA Comparison
Compare ETON & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- GNTA
- Stock Information
- Founded
- ETON 2017
- GNTA 2014
- Country
- ETON United States
- GNTA Italy
- Employees
- ETON N/A
- GNTA N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ETON Health Care
- GNTA Health Care
- Exchange
- ETON Nasdaq
- GNTA Nasdaq
- Market Cap
- ETON 199.5M
- GNTA 67.4M
- IPO Year
- ETON 2018
- GNTA 2021
- Fundamental
- Price
- ETON $8.82
- GNTA $5.34
- Analyst Decision
- ETON Strong Buy
- GNTA Strong Buy
- Analyst Count
- ETON 3
- GNTA 1
- Target Price
- ETON $12.00
- GNTA $25.00
- AVG Volume (30 Days)
- ETON 214.1K
- GNTA 28.4K
- Earning Date
- ETON 11-11-2024
- GNTA 01-01-0001
- Dividend Yield
- ETON N/A
- GNTA N/A
- EPS Growth
- ETON N/A
- GNTA N/A
- EPS
- ETON N/A
- GNTA N/A
- Revenue
- ETON $31,381,000.00
- GNTA N/A
- Revenue This Year
- ETON $19.61
- GNTA N/A
- Revenue Next Year
- ETON $35.39
- GNTA N/A
- P/E Ratio
- ETON N/A
- GNTA N/A
- Revenue Growth
- ETON 8.14
- GNTA N/A
- 52 Week Low
- ETON $3.03
- GNTA $2.20
- 52 Week High
- ETON $8.66
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ETON 76.07
- GNTA 56.89
- Support Level
- ETON $7.58
- GNTA $4.89
- Resistance Level
- ETON $8.66
- GNTA $6.20
- Average True Range (ATR)
- ETON 0.42
- GNTA 0.70
- MACD
- ETON -0.07
- GNTA -0.06
- Stochastic Oscillator
- ETON 91.49
- GNTA 37.32
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.